Cellectis S.A. (CLLS)
NASDAQ: CLLS · IEX Real-Time Price · USD
2.550
+0.080 (3.24%)
Apr 19, 2024, 4:30 PM EDT - Market closed
Cellectis Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 89.79 | 185.64 | 241.15 | 340.52 | 451.5 | 256.38 | 254.57 | 369.86 | 132.23 | 8.9 |
Short-Term Investments | 7.91 | 0.5 | 27.09 | 20.39 | 0.39 | 40.6 | 36.59 | 0 | 0 | 0 |
Cash & Cash Equivalents | 97.7 | 186.14 | 268.24 | 360.91 | 451.89 | 296.98 | 291.16 | 369.86 | 132.23 | 8.9 |
Cash Growth | -47.51% | -30.61% | -25.68% | -20.13% | 52.16% | 2.00% | -21.28% | 179.70% | 1386.27% | - |
Receivables | 15.27 | 29.63 | 15.87 | 12.1 | 20.14 | 12.28 | 12.35 | 17.82 | 16.54 | 10.39 |
Inventory | 0 | 0 | 1.61 | 2.9 | 0.28 | 0.25 | 0.12 | 0.19 | 0.16 | 0.43 |
Other Current Assets | 9.08 | 9.67 | 29.64 | 15.62 | 15.33 | 13.71 | 8.87 | 5.51 | 6.44 | 3.76 |
Total Current Assets | 122.04 | 225.43 | 315.36 | 391.52 | 487.64 | 323.22 | 312.5 | 393.37 | 155.37 | 23.47 |
Property, Plant & Equipment | 107.9 | 148.27 | 145.52 | 69.32 | 10.04 | 7.23 | 16.9 | 5.94 | 3.07 | 4.55 |
Long-Term Investments | 8.79 | 6.52 | 7.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangibles | 0.72 | 1.85 | 1.58 | 1.11 | 1.27 | 1.43 | 1.34 | 1.13 | 1.21 | 5.45 |
Other Long-Term Assets | 21.77 | 0 | 0 | 5.52 | 1.89 | 1 | 0.69 | 0.99 | 2.33 | 0.51 |
Total Long-Term Assets | 139.17 | 156.65 | 154.11 | 75.95 | 13.2 | 9.66 | 18.93 | 8.06 | 6.61 | 10.51 |
Total Assets | 261.22 | 382.08 | 469.47 | 467.47 | 500.84 | 332.88 | 331.43 | 401.43 | 161.97 | 33.99 |
Accounts Payable | 21.46 | 23.76 | 24.61 | 29.26 | 15.88 | 9.46 | 9.72 | 7.78 | 11.54 | 11.42 |
Deferred Revenue | 0.06 | 0.3 | 0.45 | 20.03 | 20.75 | 27.98 | 38.93 | 64.45 | 70.02 | 6.61 |
Current Debt | 12.96 | 10.68 | 6.7 | 1.07 | 0.33 | 0.02 | 1.73 | 2.26 | 1.01 | 0.81 |
Other Current Liabilities | 13.66 | 14.6 | 20.26 | 12.24 | 9.9 | 8 | 5.79 | 16.07 | 5.54 | 7.7 |
Total Current Liabilities | 48.13 | 49.35 | 52.02 | 62.6 | 46.87 | 45.45 | 56.17 | 90.56 | 88.12 | 26.54 |
Long-Term Debt | 69.89 | 91.56 | 104.6 | 46.54 | 1.02 | 0.01 | 0.03 | 0.08 | 3.32 | 3.97 |
Other Long-Term Liabilities | 17.26 | 4.7 | 4.01 | 2.86 | 2.68 | 3.43 | 0.56 | 0.51 | 0.47 | 0.51 |
Total Long-Term Liabilities | 87.14 | 96.25 | 108.61 | 49.4 | 3.7 | 3.44 | 0.59 | 0.59 | 3.79 | 4.49 |
Total Liabilities | 135.28 | 145.6 | 160.63 | 112 | 50.57 | 48.9 | 56.76 | 91.15 | 91.91 | 31.02 |
Total Debt | 82.85 | 102.24 | 111.3 | 47.61 | 1.35 | 0.03 | 1.76 | 2.34 | 4.34 | 4.79 |
Debt Growth | -18.97% | -8.14% | 133.78% | 3423.83% | 3873.53% | -98.07% | -24.74% | -46.09% | -9.35% | - |
Retained Earnings | -439.5 | -698.33 | -587.04 | -508.48 | -405.32 | -353.07 | -275.13 | -185.65 | -155.97 | -156.11 |
Comprehensive Income | -28.61 | -18.02 | -4.09 | -22.64 | -16.67 | 1.83 | -22.17 | -1.92 | -0.9 | 0.97 |
Shareholders' Equity | 117.97 | 221.29 | 283.8 | 315.12 | 409.3 | 264.87 | 272.8 | 309.43 | 71.55 | 3.22 |
Net Cash / Debt | 14.85 | 83.9 | 156.94 | 313.3 | 450.54 | 296.95 | 289.4 | 367.52 | 127.89 | 4.11 |
Net Cash / Debt Growth | -82.30% | -46.54% | -49.91% | -30.46% | 51.72% | 2.61% | -21.26% | 187.36% | 3010.82% | - |
Net Cash Per Share | - | - | - | - | - | - | - | 10.65 | 4.88 | - |
Working Capital | 73.91 | 176.08 | 263.35 | 328.92 | 440.77 | 277.77 | 256.33 | 302.82 | 67.25 | -3.06 |
Book Value Per Share | 2.59 | 4.87 | 6.68 | 7.43 | 9.65 | 7.50 | 7.75 | 9.06 | 2.74 | - |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).